Background/Aims: Hyperglycemia has been shown to increase the incidence and metastasis in various types of cancers. However, the correlation between hyperglycemia and lymphatic metastasis in prostate cancer (PCa) remains unclear. Our previous study demonstrated that
Introduction
Prostate cancer (PCa) is one of the most common male cancers, and androgenindependent PCa cells are highly malignant and metastatic [1] . Since lymph nodes adjacent to the primary tumor, advanced PCa cells often invade into lymph nodes via lymphangiogenesis [2, 3] and then spread to other organs through the lymphatic system, which is known as lymphatic metastasis [4] . Therefore, how to inhibit PCa-induced lymphangiogenesis as well as lymphatic metastasis are critical to control PCa progression in patients.
Lysophosphatidic acid (LPA), a bioactive lysophospholipid, is implicated in several physiological functions, including cell proliferation, migration, angiogenesis and lymphangiogenesis [5] [6] [7] [8] [9] . To date, six G protein-coupled receptors, including LPA 1~6 , were identified to mediate the cellular functions of LPA. Interestingly, PCa cells generate and secret LPA [10] . Autotaxin (ATX) [11] , the major LPA-synthesizing enzyme for extracellular LPA production [12] was highly expressed in PCa cells. These results indicated that PCa might utilize an autocrine mechanism to control LPA production and their-mediated cellular functions. In addition, our previous study showed that extracellular LPA up-regulates the expression of vascular endothelial growth factor (VEGF)-C, a lymphangiogenic factor, in PCa cells [5] . VEGF-C binds to VEGF receptor-3 (VEGFR-3) and activates the subsequent signaling events in lymphatic endothelial cells [13] . Moreover, we revealed that LPA-induced VEGF-C via generating reactive oxygen species (ROS) and lens epithelium-derived growth factor (LEDGF) [5, 9] . Since PCa-releasing VEGF-C has been shown to mediate lymphatic metastasis [14] , blocking LPA-mediated signaling might be a potential strategy to confine metastasis of PCa.
Several studies have reported that elevated blood glucose (hyperglycemia) in type II diabetes mellitus (DM) is positively associated with cancer incidence and cancer progression [15, 16] . Hyperglycemia also increases the incidence and metastasis of various types of cancer [17] [18] [19] . However, the potential physiological links and the molecular mechanism between hyperglycemia and PCa remain unclear. It has been known that the proliferation of PCa cells is associated with elevated glucose consumption [20] . This might be due to malignant tumor cells typically have much higher glycolytic rates than normal tissues of origin [21] . Interestingly, hyperglycemia increases ATX expression in the adipocytes [22] . Furthermore, previous studies demonstrated that high glucose induces VEGF-A production in human synovial fibroblast [23] and HUVEC [24] . In addition, Ca 2+ binding chaperone calreticulin (CRT), acts as a stress-related unfolding protein response (UPR) protein [25] , plays a role in the pathophysiology of DM [26] . We recently revealed that CRT induces VEGF-A [27] in neuroblastoma cells. Since PCa cells express ATX and release VEGF-C in response to LPA, herein, we proposed that hyperglycemia induces ATX expression and therefore mediates LPA-VEGF-C signaling in PCa cells. In this study, we showed that high glucose treatments indeed increased ATX and VEGF-C in PC-3 cells. Moreover, high glucose-induced VEGF-C expression was mediated through the LPA 1/3 , PLC, Akt, ROS and LEDGF-dependent pathways. Furthermore, high glucose also enhanced the aerobic glycolysis via LPA 1/3 . Taken together, our results indicate that hyperglycemia promotes LPA synthesis via ATX and subsequently enhances VEGF-C expression. These novel findings proposed a correlation of DM to PCainduced lymphatic metastasis and therefore provide new treatment strategies for PCa. 
Statistical analysis
Data were analyzed by one-way analysis of variance (ANOVA) and Fisher's protected least significant difference (LSD) test (StatView; Abacus Concept, Berkeley, CA, USA). Each result was obtained after three to six independent experiments, and P value of < 0.05 was considered statistically significant.
Results

High glucose upregulates VEGF-C expression in PC-3 cells
Several studies have indicated that hyperglycemia increases the incidence and metastasis in many cancers [17] [18] [19] . Lymphangiogenesis and angiogenesis are two important characteristics in cancer progression [28] .
Although some studies indicate that hyperglycemia induces VEGF production, which may leads to angiogenesis in human synovial fibroblasts and HUVECs [23, 24] , little is known about the relationships between hyperglycemia Serum-starved PC-3 cells were treated with or without an additional 20 mM of glucose or cultured in glucose-free RPMI medium for 4 hours, and the mRNA expressions of VEGF-A, VEGF-C, FGF-2, and PDGF-BB were then assessed. (B) PC-3 and (C) LNCaP cells were incubated with an additional 10 and 20 mM of glucose (B and C) or mannitol (D) for 2 or 4 hours, and the VEGF-C mRNA (B~D) and protein expressions (E) were then determined by real-time PCR and western blotting, respectively. Cells cultivation in 10 mM of glucose-containing RPMI media were used as the untreated control (set to 1.0), and data were shown as multiples of that. The results are expressed as mean ± SEM. *p<0.05; **p<0.01 compared with untreated control (n ≧ 3). UT, untreated control. Results showed that only the mRNA expression of VEGF-C was augmented upon high glucose stimulation (Fig. 1A) . Moreover, the mRNA (Fig. 1B) and protein ( Fig. 1E ) expressions of VEGF-C were upregulated through high glucose (20 mM) stimulation for 4 and 8 hours, respectively, in PC-3 cells, but not in LNCaP cells (Fig. 1C) . To exclude the side effects from the osmotic pressure, the same concentrations of D-mannitol were applied. Results indicated that D-mannitol had no effect on the VEGF-C mRNA levels in PC-3 and LNCaP cells (Fig. 1D) . These results indicated that abnormally high glucose conditions upregulate the VEGF-C expression in malignant PCa cells.
High glucose upregulates the VEGF-C expression via induction of autotaxin in PC-3 cells
Previous studies revealed that hyperglycemia up-regulates ATX expression in diabetic mice [22] . Moreover, the ATX/LPA signaling axis is associated with tumor progression and metastasis in many cancers, including PCa [5] . Hence, we proposed that ATX might play an important role on high glucose-induced VEGF-C expression in PC-3 cells. To this end, ATX expression levels were firstly assessed following high glucose stimulation. The results showed that ATX mRNA ( Fig. 2A) and protein ( Fig. 2D ) expression were upregulated following 20 mM of glucose stimulation for 4 and 8 hours, respectively, in the PC-3 cells, but not in the LNCaP cells (Fig. 2B) . These results were not from the osmotic pressure (Fig. 2C ). To further confirm that ATX is involved in high glucose-induced VEGF-C expression in PC-3 cells, an ATX inhibitor (S32826) and its specific siRNAs were applied. Results indicated that high glucose- were then determined by realtime PCR and western blotting, respectively. Serum starved PC-3 cells were pretreated with 200 nM of S32826 for 1 hour, followed by incubation of an additional 20 mM of glucose for another 4 (E) or 8 hours (F), then assessing the VEGF-C mRNA (E) and protein (F) expressions by real-time PCR and western blotting, respectively. Cell cultivation in 10 mM of glucosecontaining RPMI media was used as the untreated control (set to 1.0), and data were shown as multiples of that. The results are expressed as mean ± SEM. *p<0.05; **p<0.01 compared with untreated control (n ≧ 3).
# p<0.05 compared with glucose-treated group. UT, untreated control. induced VEGF-C mRNA and protein expression were both suppressed upon either S32826 co-treatment ( Fig. 2E and 2F ) or ATX siRNA transfection in the PC-3 cells. Taken together, these results indicated that ATX is responsible for high glucose-induced VEGF-C expression in PC-3 cells.
High glucose upregulates VEGF-C expression via induction of calreticulin in PC-3 cells
Previous studies have shown that CRT expression levels are significantly upregulated in PCa [29] . Moreover, we recently demonstrated that CRT induced VEGF-A [27] and VEGF-C (unpublished results) expression in neuroblastoma cells. Furthermore, CRT also played a role in LPA-induced VEGF-A expression in PC-3 cells (unpublished results). These results indicated that CRT might contribute significantly to PCa progression. Thus, we hypothesized that CRT may also participate in high glucose-induced VEGF-C expression in PC-3 cells. Results showed that 10 and 20 mM glucose induced CRT mRNA expression within 2 hours (Fig. 3A) , and also enhanced its protein expression after 8 hours (Fig. 3D ) in PC-3 cells, but not in LNCaP cells (Fig. 3B) . To further confirm the role of CRT in high glucose-induced VEGF-C expression in PC-3 cells, CRT shRNA was applied. Results showed that the high glucose-induced VEGF-C mRNA (Fig. 3F ) and protein ( Fig. 3G ) expressions were abolished upon seeing the CRT knockdown (Fig. 3E ), indicating that CRT is involved in high glucoseinduced VEGF-C expression in PC-3 cells.
To investigate whether CRT-induced VEGF-C expression resulted from the regulation of ATX under the high glucose condition, the ATX protein expression was monitored during the CRT shRNA application. Results showed that ATX protein expression was suppressed following the knockdown of CRT, leading to a decrease of VEGF-C expression in PC-3 cells (Fig. 3H) . On the other hand, knockdown of ATX attenuates the VEGF-C expression, but not the CRT expression ( Fig. 3I and 3J ). Taken together, these results indicated that CRT is an upstream regulator for ATX and is responsible for the high glucose-induced VEGF-C expression in PC-3 cells.
High glucose-induced VEGF-C expression is mediated through the LPA 1/3 receptors signaling in PC-3 cells
It has been well-known that ATX is a critical molecule for LPA production, which is considerably correlated to cancer progression [30] . Moreover, our previous studies have revealed that the LPA upregulated VEGF-C expression in human endothelial cells and PC-3 cells [5, 6, 9] . To determine whether the high glucose-induced VEGF-C is LPA-dependent, Ki16425, a potent LPA 1/3 antagonist, and their specific shRNAs were applied. The results showed that the high glucose-induced VEGF-C mRNA expression was obviously abolished by Ki16425 co-treatment in PC-3 cells (Fig. 4A) , indicating that LPA 1 or LPA 3 signaling is responsible for the high glucose-induced VEGF-C expression. To further confirm whether LPA 1 and/or LPA 3 are involved in the high glucose's effects on VEGF-C induction, the LPA 1 and LPA 3 stably knockdown of PC-3 cells were generated ( Fig. 4B and 4C) . Results showed that both the LPA 1 and LPA 3 knockdown cells attenuated the high glucose-induced VEGF-C expression (Fig. 4D) . To further investigate which G protein is involved in LPA 1/3 -dependent signaling in high glucose-induced VEGF-C expression, various G protein inhibitors were applied. Results showed that the GP antagonist-2 and GP antagonist-2A, but not Y-27632, were suppressed through the high glucose-induced VEGF-C mRNA expression (Fig. 4E) , indicating that high glucose-induced VEGF-C expression is mediated through G i and G q , but not G 12/13 protein in PC-3 cells. To further decipher the molecular mechanism of LPA on the high glucose-induced VEGF-C expression, PLC and Akt, two intracellular signaling pathways, were assessed. Results showed that the high glucose-induced VEGF-C expression was abolished once the U73122 and LY294002 treatments in the PC-3 cells were applied. (Fig.  4F) . These results indicated that the high glucose-induced VEGF-C expression is mediated through the LPA 1/3 -PLC-Akt signaling pathway in PC-3 cells.
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High glucose-induced VEGF-C expression is mediated through the LPA 1/3 -PLC-Akt-ROS-LEDGF-dependent signaling axis in PC-3 cells
The reactive oxygen species (ROS) and lens epithelium-derived growth factor (LEDGF) were downstream of the LPA signals that are involved in the LPA-induced VEGF-C expression in PC-3 cells [5] . To decipher the intracellular signaling mechanism of high glucose-induced VEGF-C expression, ROS and LEDGF signaling were determined. We showed that the ROS was augmented through 10 and 20 mM glucose stimulation in PC-3 cells (Fig. 5A) . To confirm whether high glucose-enhanced ROS is responsible for the VEGF-C induction in PC-3 cells, the ROS inhibitor, N-acetylcysteine (NAC), was applied. Compared to the control group, 1 shRNA, or LPA 3 shRNA, followed by treatment with an additional 20 mM of glucose for 4 hours. Then the VEGF-C mRNA expressions were assessed. PC-3 cells were pre-incubated with (E) 10 μM of GP antagonist-2A, GP antagonist-2, Y-27632, or (F) 2 μM of U73122, 10 μM of LY294002 for 1 hour prior to treatment with an additional 20 mM of glucose for another 4 hours. The VEGF-C mRNA expressions were then determined by real-time PCR analysis. Cells with or without transfection with the mock vector cultivation in 10 mM of glucose-containing RPMI media were used as the untreated control (set to 1.0), and data were shown as multiples of that. The results are expressed as mean ± SEM. *p<0.05; **p<0.01; ***p<0.001 compared with untreated control (n ≧ 3).
# p<0.05; ### p<0.001 compared with glucose-treated group. UT, untreated control. 
pretreatment of NAC suppressed the high glucose-induced VEGF-C mRNA expression (Fig.  5C ), but not affecting the cell viability (Fig. 5B) . Next, we monitored the LEDGF expression following the high glucose stimulation in PC-3 cells. Our results indicated that the LEDGF mRNA significantly increased following the 10 and 20 mM glucose treatment in the PC-3 cells (Fig. 5D) . Moreover, knockdown of the LEDGF by its specific shRNA (Fig. 5E) abolished the effects of the high glucose on the VEGF-C induction (Fig. 5F ). To determine whether the effects of ROS and LEDGF on the high glucose-induced VEGF-C expression were LPAdependent, the LPA receptor signaling was blocked. The results showed that high glucoseinduced LEDGF and ROS were suppressed through either Ki16425 stimulation or LPA 1/3 shRNA transfection (Fig. 5G~J) . To further study the signaling axis of ROS and LEDGF on high glucose-induced VEGF-C expression, the LEDGF mRNA expression was monitored via NAC treatment. The results showed that the high glucose-induced LEDGF mRNA expression was obviously attenuated through NAC pretreatment (Fig. 5K) . Taken together, these results indicated that high glucose-induced VEGF-C expression is mediated through the LPA 1/3 -ROS-LEDGF signaling axis in the PC-3 cells.
LPA 1/3 is involved in the high glucose-upregulated aerobic glycolysis in PC-3 cells
Alteration of metabolism is one of the hallmarks of cancer cells, referred to as aerobic glycolysis or the Warburg effect [21] . Additionally, hyperglycemia is believed to be an independent risk factor for the development of many cancers [31] . Moreover, it has been shown that LPA up-regulates hexokinase activity and glycolysis in ovarian cancer cells [32] . To investigate the roles of hyperglycemia and LPA on metabolism in PCa cells, cellular bioenergetics were determined. The results showed that 20 mM glucose up-regulates the extracellular acidification rate (ECAR), an indicator of glycolysis (Fig. 6A) , and the cellular oxygen consumption rate (OCR), an indicator of mitochondrial respiration (Fig.  6B) . Meanwhile, LPA also showed a similar effect on cellular bioenergetics (Fig. 6A and  6B ), indicating that both high glucose and LPA up-regulates glycolysis in PC-3 cells. To further confirm whether high glucose-upregulated glycolysis is LPA-dependent, Ki16425 was applied. The results revealed that both high glucose-augmented ECAR and OCR were abolished through Ki16425 co-treatment in PC-3 cells (Fig. 6C and 6D) . Interestingly, not only the basal levels of ECAR but also basal OCR were both reduced when LPA 1/3 signaling is blocked by Ki16425 treatment (Fig. 6E and 6F ). Cells were then treated oligomycin, carbonyl cyanide p-trifluoromethoxy-phenylhydrazone (FCCP), and antimycin & rotenone in order to obtain the levels of ATP production and spare respiratory capacity. Both ATP production and spare respiratory capacity were also decreased upon Ki16425 treatment (Fig. 6G) . Reduced oxygen consumption may result in the reduced mitochondrial ROS production. Moreover, our result is consistent with our previous study indicated that LPA 1/3 signals are necessary for the ROS production. Meanwhile, we performed Glycolysis Stress Test in Ki16425-pretreated cells. After Ki16425 treatment, cells were incubated in serum-free medium for additional 1h, and then sequentially treated with glucose, oligomycin, and 2-deoxyglucose (2-DG). However, Ki16425 did not alter the glycolysis in PC-3 cells (Fig. 6H) . Taken together, our results imply that LPA 1/3 is critical for the mitochondrial respiration rather than glycolysis in PC-3 cells.
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Discussion
Several clinical studies and metaanalyses have revealed that hyperglycemia showed the positive correlation with many types of cancers, including liver, pancreas, colorectal, kidney, bladder, endometrial, and breast cancers [15, 16] . Additionally, hyperglycemia increases the incidence and mortality of cancers [33] . Moreover, high glucose promotes the growth and metastasis of cancer cells in vivo [20, 34] . However, the effect of high glucose on PCa is still controversial. Although some studies indicate that type II DM increases the incidence of PCa because of the lower levels of androgen in diabetic patients [34, 35] , others showed the opposite results 14. Furthermore, high glucose promotes the growth of androgen-independent A and B) . The extracellular acidification rate (ECAR) (A and C) and cellular oxygen consumption rate (OCR) (B and D) were then determined within 1 hour. PC-3 cells were treated with Ki16425 (5 μM) or DMSO for 1 hour, and subjected into Mito Stress Test and Glycolysis Stress test. The real-time OCR (E) and ECAR (F) were detected every 8 min within 100 min by Seahorse XF e 24 Analyzer. Oligomycin (1 μM), FCCP (0.5 μM), and rotenone/antimycin A (0.5 μM) were injected at indicated times. Basal respiration, basal ECAR, ATP production, and spare respiration capacity were analyzed by Wave software. (H) The real-time glycolysis rate were analyzed by Glycolysis Stress Test. Ki16425-and DMSO-treated cells were cultured in glucosefree medium for 1 hour prior to Glycolysis Stress Test. Subsequently, glucose, oligomycin, and 2-DG were injected in order to the cells. The results are expressed as mean ± SEM. *p<0.05; **p<0.01; ***p<0.001 compared with untreated control (n ≧ 3).
# p<0.05; ## p<0.01; ### p<0.001 compared with glucose-treated group. UT, untreated control. (Fig. 1) . LPA has been reported to induce VEGF-A and VEGF-C expressions [5, [7] [8] [9] , as well as enhance tumor cell proliferation and migration 36, indiating that LPA is critival for tumor progression and metastasis. On the other hand, previous studies indicated that hyperglycemia increases LPA production by up-regulating ATX expression in diabetic mice 22. Moreover, elevated serum levels of VEGF-C were found in obese patients and its level contributes to the development of insulin resistance 37. These results were similar with our observations indicating that high glucose induces ATX and VEGF-C expression which is mediated through LPA 1/3 (Fig 4) . These results suggested that the blockage of VEGF-C or LPA/ATX may be a suitable approach to alleviate the development of type II diabetes.
VEGFs have been implicated in angiogenesis and lympangiogenesis [4, 24, 38, 39 ] that play critical roles during the progression of cancer. Thus, the anti-angiogenic or antilympangiogenic molecules exert their beneficial effects on cancer therapy 40. Our previous studies have revealed that LPA-induced VEGF-C expression is mediated through LPA 1/3 , PLC, protein kinase-C (PKC), ROS and LEDGF signaling pathway [5, [7] [8] [9] . Additionaly, high glucose increases ROS production via PKC-dependent pathways in smooth muscle and endothelial cells 41. Herein, we showed for the first time that high glucose induces VEGF-C expression via the LPA 1/3 -ROS-LEDGF-dependent signaling in PC-3 cells (Fig. 4 and 5) . On the other hand, in silico analysis indicated that the LEDGF binding sites were identified in the promoter region of the human VEGF-C 42. Furthermore, LEDGF enhances VEGF-C expression in vitro and enhances angiogenesis and lymphangiogenesis in vivo 42. These results suggested that LEDGF may serve as a potential target for anticancer therapy.
CRT, a multifunctional chaperone protein, regulates various biological functions, including cell adhesion and post-transcription regulation [43, 44] . The expression levels of CRT correlated with cancer progression and lymphatic metastasis 45. On the other hand, CRT destabilizes the glucose transporter-1 mRNA expression in vascular endothelial and smooth muscle cells under high-glucose conditions 46. Moreover, our unpublished data suggested that CRT expression is regulated by LPA activation. Herein, we showed that high glucose enhances CRT and ATX expressions in PC-3 cells (Fig. 2 and 3 ). In addition, ATX interacts with tumor cells by binding to integrin α V β 3 to mediate LPA production in breast cancer cells 47. Through analyzing the AU-rich element (ARE) database, we found that ATX has 4 AU-rich domains (data not shown). Meanwhile, CRT plays as an upstream regulator for high glucose-induced ATX expression in PC-3 cells (Fig. 3I) . Hence, we hypothesized that CRT might regulate ATX expression by enhancing its mRNA stability or regulating its integrin interactions, which leads to LPA production and subsequent induction of VEGF-C in PC-3 cells.
Glucose-lowering therapy is a method for diabetes treatment by using anti-hyperglycemic medications to control blood sugar levels. Recent studies have suggested that these hypoglycemic drugs, such as metformin, decrease the prostate specific antigen (PSA) level, epithelial-mesenchymal transition (EMT) and proliferation of PCa [48] [49] [50] . These studies confirm our present study showing that hyperglycemia drives PCa progressions. Therefore, the combination with anti-hyperglycemic drugs and anti-lymphangiogenic therapy could potentially provide a new strategy for preventing lymphangiogenesis in PCa.
Conclusion
In conclusion, these results suggested that abnormal glucose metabolism might lead to LPA synthesis and therefore up-regulates aerobic glycolysis and VEGF-C production in PCa. These novel findings could potentially provide new evidence for glucose-lowering therapies in PCa.
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